Will Sudeep Pharma’s IPO stand out as a long-term growth opportunity?
ET Intelligence Group: Sudeep Pharma, a pharmaceutical and specialty nutrition company, plans to raise ₹95 crore through fresh issue to fund capex. It also has an offer for sale of upto ₹800 crore. The promoter group’s stake will fall to 76.2% after the IPO from 89.4%. It plans to raise the manufacturing capacity by 50,000…